AYTU saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 02, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 52 instances where the indicator turned negative. In 48 of the 52 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on October 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AYTU as a result. In 80 of 97 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
AYTU moved below its 50-day moving average on September 28, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AYTU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for AYTU entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AYTU's RSI Indicator exited the oversold zone, 32 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where AYTU advanced for three days, in 165 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Tickeron Valuation Rating of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.610) is normal, around the industry mean (10.407). P/E Ratio (-1.707) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (0.320) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. AYTU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AYTU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The RSI Indicator for TLPH moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 24 of the 26 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for TLPH just turned positive on October 20, 2026. Looking at past instances where TLPH's MACD turned positive, the stock continued to rise in 42 of 46 cases over the following month. The odds of a continued upward trend are 90%.
Following a +1.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLPH advanced for three days, in 179 of 223 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
TLPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLPH as a result. In 80 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLPH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TLPH entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. TLPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.783) is normal, around the industry mean (10.407). P/E Ratio (-4.565) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (1250.000) is also within normal values, averaging (178.797).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TLPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
AYTU | TLPH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 85 | 41 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 25 Undervalued | 93 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 99 | |
PRICE GROWTH RATING 1..100 | 73 | 58 | |
P/E GROWTH RATING 1..100 | 30 | 21 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AYTU's Valuation (25) in the Other Consumer Services industry is significantly better than the same rating for TLPH (93) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew significantly faster than TLPH’s over the last 12 months.
AYTU's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as TLPH (100) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to TLPH’s over the last 12 months.
AYTU's SMR Rating (98) in the Other Consumer Services industry is in the same range as TLPH (99) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew similarly to TLPH’s over the last 12 months.
TLPH's Price Growth Rating (58) in the Pharmaceuticals Other industry is in the same range as AYTU (73) in the Other Consumer Services industry. This means that TLPH’s stock grew similarly to AYTU’s over the last 12 months.
TLPH's P/E Growth Rating (21) in the Pharmaceuticals Other industry is in the same range as AYTU (30) in the Other Consumer Services industry. This means that TLPH’s stock grew similarly to AYTU’s over the last 12 months.
| AYTU | TLPH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 84% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| Advances ODDS (%) | 29 days ago 73% | 7 days ago 80% |
| Declines ODDS (%) | 4 days ago 85% | 9 days ago 90% |
| BollingerBands ODDS (%) | N/A | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 85% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AYTU’s FA Score shows that 2 FA rating(s) are green while TLPH’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AYTU’s TA Score shows that 3 TA indicator(s) are bullish while TLPH’s TA Score has 6 bullish TA indicator(s).
AYTU (@Pharmaceuticals: Generic) experienced а +0.51% price change this week, while TLPH (@Pharmaceuticals: Generic) price change was +0.94% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -2.94%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +9.53%.
AYTU is expected to report earnings on Nov 12, 2026.
TLPH is expected to report earnings on Nov 11, 2026.
A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
A.I.dvisor tells us that AYTU and HROW have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AYTU and HROW's prices will move in lockstep.
| Ticker / NAME | Correlation To AYTU | 1D Price Change % | ||
|---|---|---|---|---|
| AYTU | 100% | +1.02% | ||
| HROW - AYTU | 28% Poorly correlated | -0.32% | ||
| SIGA - AYTU | 28% Poorly correlated | +0.96% | ||
| ZYBT - AYTU | 27% Poorly correlated | N/A | ||
| OGI - AYTU | 25% Poorly correlated | -0.43% | ||
| IRWD - AYTU | 23% Poorly correlated | +0.56% | ||
More | ||||
A.I.dvisor tells us that TLPH and TKNO have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPH and TKNO's prices will move in lockstep.
| Ticker / NAME | Correlation To TLPH | 1D Price Change % | ||
|---|---|---|---|---|
| TLPH | 100% | -1.87% | ||
| TKNO - TLPH | 24% Poorly correlated | +5.13% | ||
| HROW - TLPH | 24% Poorly correlated | -0.32% | ||
| AYTU - TLPH | 23% Poorly correlated | +1.02% | ||
| TXMD - TLPH | 21% Poorly correlated | -2.63% | ||
| ZSTK - TLPH | 21% Poorly correlated | -5.88% | ||
More | ||||